Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin
- PMID: 23935101
- PMCID: PMC3784700
- DOI: 10.1074/jbc.M112.445098
Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin
Abstract
The vasopressin type 2 receptor (V2R) is a critical G protein-coupled receptor (GPCR) for vertebrate physiology, including the balance of water and sodium ions. It is unclear how its two native hormones, vasopressin (VP) and oxytocin (OT), both stimulate the same cAMP/PKA pathway yet produce divergent antinatriuretic and antidiuretic effects that are either strong (VP) or weak (OT). Here, we present a new mechanism that differentiates the action of VP and OT on V2R signaling. We found that vasopressin, as opposed to OT, continued to generate cAMP and promote PKA activation for prolonged periods after ligand washout and receptor internalization in endosomes. Contrary to the classical model of arrestin-mediated GPCR desensitization, arrestins bind the VP-V2R complex yet extend rather than shorten the generation of cAMP. Signaling is instead turned off by the endosomal retromer complex. We propose that this mechanism explains how VP sustains water and Na(+) transport in renal collecting duct cells. Together with recent work on the parathyroid hormone receptor, these data support the existence of a novel "noncanonical" regulatory pathway for GPCR activation and response termination, via the sequential action of β-arrestin and the retromer complex.
Keywords: Arrestin; G Protein-coupled Receptors (GPCR); Kidney Metabolism; Membrane Trafficking; Signaling; V2R.
Figures
References
-
- Lohse M. J., Benovic J. L., Codina J., Caron M. G., Lefkowitz R. J. (1990) β-Arrestin: a protein that regulates β-adrenergic receptor function. Science 248, 1547–1550 - PubMed
-
- Laporte S. A., Miller W. E., Kim K. M., Caron M. G. (2002) β-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a β-arrestin binding site in β2-adaptin. J. Biol. Chem. 277, 9247–9254 - PubMed
-
- Nelson C. D., Perry S. J., Regier D. S., Prescott S. M., Topham M. K., Lefkowitz R. J. (2007) Targeting of diacylglycerol degradation to M1 muscarinic receptors by β-arrestins. Science 315, 663–666 - PubMed
-
- Perry S. J., Baillie G. S., Kohout T. A., McPhee I., Magiera M. M., Ang K. L., Miller W. E., McLean A. J., Conti M., Houslay M. D., Lefkowitz R. J. (2002) Targeting of cyclic AMP degradation to β2-adrenergic receptors by β-arrestins. Science 298, 834–836 - PubMed
-
- Luttrell L. M., Lefkowitz R. J. (2002) The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115, 455–465 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
